The Company’s operating segments are reported in a manner consistent with the internal reporting provided to, and regularly reviewed by, the chief operating decision maker (“CODM”), the Chief Executive Officer (“CEO”), and are aligned to the four geographical hubs that the Company operates in: Americas, Europe, ASPA, and MEAI. Due to the materiality, ASPA and MEAI are aggregated into one reportable segment APMA (“Asia Pacific, Middle East, Africa”). As such the Company has three reportable segments – Americas, Europe and APMA. Additionally, the Company has Corporate / Other revenue and expenses, which primarily consists of non-core activities from the cosmetics and sleeping systems businesses, as well as other administrative costs that are not charged to the operating segments. The CODM uses the measure of adjusted EBITDA to assess operating segments’ performance to make decisions regarding the allocation of resources.

The adjustments to EBITDA relate to the effect of IPO-related costs, realized and unrealized foreign exchange gain / (loss), share-based compensation, secondary offering related costs and other adjustments relating to non-recurring items such as restructuring.

Assets and liabilities are neither reported nor reviewed by the CODM at the operating segment level.


	Year ended September 30, 2024
	Americas		Europe		APMA		Total Reportable Segments		Corporate / Other			Total
Sales		943,710		644,888		211,810		1,800,408		4,282			1,804,690
Adjusted EBITDA		301,266		218,224		65,814		585,304		(30,349	)		554,955
IPO-related costs													(7,460	)
Realized and unrealized FX gains / losses													(19,641	)
Share-based compensation													(3,591	)
Secondary offering related costs													(1,890	)
EBITDA													522,373
Depreciation and amortization													(101,291	)
Finance cost, net													(127,300	)
Profit before tax													293,782


	Year ended September 30, 2023
	Americas		Europe		APMA		Total Reportable Segments		Corporate / Other			Total
Sales		804,690		529,507		152,424		1,486,621		5,290			1,491,911
Adjusted EBITDA		291,712		167,407		44,488		503,607		(20,901	)		482,706
IPO-related costs													(30,603	)
Realized and unrealized FX gains / losses													(36,056	)
Share-based compensation													(65,393	)
Other													(6,553	)
EBITDA													344,101
Depreciation and amortization													(83,413	)
Finance cost, net													(107,036	)
Profit before tax													153,652


	Year ended September 30, 2022
	Americas		Europe		APMA		Total Reportable Segments		Corporate / Other			Total
Sales		667,387		449,131		123,033		1,239,551		3,282			1,242,833
Adjusted EBITDA		259,944		146,592		38,973		445,509		(10,954	)		434,555
Effects from applying the acquisition method of accounting for the Transaction													(24,367	)
Transaction related advisory costs													(2,598	)
Consulting fees relating to Group transformation													(7,982	)
Realized and unrealized FX gains / losses													45,516
Other													(836	)
EBITDA													444,288
Depreciation and amortization													(81,261	)
Finance cost, net													(112,503	)
Profit before tax													250,524

During the periods presented in these consolidated financial statements, the Company did not have any customers with individual revenue of 10% or greater of total revenue.